Apontis Pharma AG APPH.DE Stock
Apontis Pharma AG Price Chart
Apontis Pharma AG APPH.DE Financial and Trading Overview
| Apontis Pharma AG stock price | 8.4 EUR |
| Previous Close | 8.24 EUR |
| Open | 8.26 EUR |
| Bid | 8.16 EUR x N/A |
| Ask | 8.4 EUR x N/A |
| Day's Range | 8.26 - 8.26 EUR |
| 52 Week Range | 5.9 - 12.7 EUR |
| Volume | 100 EUR |
| Avg. Volume | 12.9K EUR |
| Market Cap | 70.55M EUR |
| Beta (5Y Monthly) | 1.754716 |
| PE Ratio (TTM) | 25.812502 |
| EPS (TTM) | -1.33 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.7 EUR |
APPH.DE Valuation Measures
| Enterprise Value | 33.29M EUR |
| Trailing P/E | 25.812502 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.2659239 |
| Price/Book (mrq) | 1.6553108 |
| Enterprise Value/Revenue | 0.597 |
| Enterprise Value/EBITDA | 6.698 |
Trading Information
Apontis Pharma AG Stock Price History
| Beta (5Y Monthly) | 1.754716 |
| 52-Week Change | -20.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.7 EUR |
| 52 Week Low | 5.9 EUR |
| 50-Day Moving Average | 9.47 EUR |
| 200-Day Moving Average | 8.77 EUR |
APPH.DE Share Statistics
| Avg. Volume (3 month) | 12.9K EUR |
| Avg. Daily Volume (10-Days) | 4.09K EUR |
| Shares Outstanding | 8.5M |
| Float | 4.62M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 26.34% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 4.82% |
| Operating Margin (ttm) | 5.69% |
| Gross Margin | 62.79% |
| EBITDA Margin | 8.91% |
Management Effectiveness
| Return on Assets (ttm) | 3.48% |
| Return on Equity (ttm) | 6.53% |
Income Statement
| Revenue (ttm) | 55.73M EUR |
| Revenue Per Share (ttm) | 6.69 EUR |
| Quarterly Revenue Growth (yoy) | -0.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | 4.97M EUR |
| Net Income Avi to Common (ttm) | 2.69M EUR |
| Diluted EPS (ttm) | 0.32 |
| Quarterly Earnings Growth (yoy) | -76.70% |
Balance Sheet
| Total Cash (mrq) | 36.35M EUR |
| Total Cash Per Share (mrq) | 4.36 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.003 |
| Book Value Per Share (mrq) | 4.99 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 11.02M EUR |
| Levered Free Cash Flow (ttm) | 6.7M EUR |
Profile of Apontis Pharma AG
| Country | Germany |
| State | N/A |
| City | Monheim am Rhein |
| Address | Alfred-Nobel-Str. 10 |
| ZIP | 40789 |
| Phone | 49 2173 8955 4949 |
| Website | https://apontis-pharma.de |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 134 |
Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.
Q&A For Apontis Pharma AG Stock
What is a current APPH.DE stock price?
Apontis Pharma AG APPH.DE stock price today per share is 8.4 EUR.
How to purchase Apontis Pharma AG stock?
You can buy APPH.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Apontis Pharma AG?
The stock symbol or ticker of Apontis Pharma AG is APPH.DE.
Which industry does the Apontis Pharma AG company belong to?
The Apontis Pharma AG industry is Drug Manufacturers-Specialty & Generic.
How many shares does Apontis Pharma AG have in circulation?
The max supply of Apontis Pharma AG shares is 8.5M.
What is Apontis Pharma AG Price to Earnings Ratio (PE Ratio)?
Apontis Pharma AG PE Ratio is now.
What was Apontis Pharma AG earnings per share over the trailing 12 months (TTM)?
Apontis Pharma AG EPS is -1.33 EUR over the trailing 12 months.
Which sector does the Apontis Pharma AG company belong to?
The Apontis Pharma AG sector is Healthcare.